Emergent BioSolutions (EBS) Price to Sales (2011 - 2026)
Emergent BioSolutions' (EBS) Price to Sales was 0.56 for Q2 2026, up 38.7% from 0.40 a year earlier but down 12.1% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Price to Sales at Emergent BioSolutions was 0.87, up 74.3% from FY2024.
- By year, Price to Sales came in at 0.50 in FY2024 (+316.6%), 0.12 in FY2023 (-77.5%), 0.53 in FY2022 (-57.9%) and 1.26 in FY2021 (-58.3%).
- Five-year quarterly Price to Sales spans a low of 0.11 in Q1 2024 and a high of 1.66 in Q3 2021.
- Year over year, Price to Sales has now increased in each of the last eight quarters, with growth averaging 115.9% over the last eight quarters.
- The high point for year-over-year Price to Sales in five years was Q4 2024 (growth of 316.6%); the low point was Q1 2024 (a decline of 79.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 0.64 (Q1 2026), 0.87 (Q4 2025) and 0.59 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Emergent BioSolutions | 319.92 Mn | -430.98 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.56 |
| Mar 31, 2026 | 0.64 |
| Dec 31, 2025 | 0.87 |
| Sep 30, 2025 | 0.59 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | 0.27 |
| Dec 31, 2024 | 0.50 |
| Sep 30, 2024 | 0.40 |
| Jun 30, 2024 | 0.33 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.12 |
| Sep 30, 2023 | 0.16 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.69 |
| Jun 30, 2022 | 0.99 |
| Mar 31, 2022 | 1.22 |
| Dec 31, 2021 | 1.26 |
| Sep 30, 2021 | 1.66 |
API Access
Emergent BioSolutions Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();